| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |